跳至主要内容
临床试验/CTRI/2009/091/000590
CTRI/2009/091/000590
招募中
1 期

Stem cell therapy- Cellular Cardio myoplasty for patients with severe ventricular dysfunction

Frontier Lifeline PvtLtd0 个研究点目标入组 90 人待定

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Frontier Lifeline PvtLtd
入组人数
90
状态
招募中
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
4年前
研究类型
Interventional

研究者

发起方
Frontier Lifeline PvtLtd

入排标准

入选标准

  • Patients aged between 0 to 60 years presenting with Dilated Cardiomyopathy or coronary artery disease (CAD) are enrolled. Patients with ventricular ejection fraction (LVEF) less than 35% are eligible for enrollement.

排除标准

  • 1\. Sustained ventricular tachycardia in a 24 hour ECG.
  • 2\. Chronic atrial fibrillation.
  • 3\. Less than 6 months since last episode of cerebral
  • infarction.
  • 4\. Less than 6 months since last coronary angioplasty or
  • less than 3 months since last bypass surgery.
  • 5\. Patients with unstable angina, with a treatment rating
  • of 3 in the Braunwald system, but a severity of III and a
  • clinical rating of B or C.
  • 6\. Presence of left ventricular thrombus by

结局指标

主要结局

未指定

相似试验